Insiders · IRWD

IRWD insider transactions

Ironwood Pharmaceuticals Inc. (IRWD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IRWD

• 17d
  PFO & PAO Silver Ronald was granted 25,000 shares, increasing direct ownership by 6% to 441,570 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 82d
  Director Denner Alexander J was granted 4,451 shares and sold $20,530,448 worth of shares (6,730,800 units at $3.05), increasing direct ownership by 2% to 256,309 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 87d
  Chief Legal Officer John Minardo was granted 136,612 shares, increasing direct ownership by 38% to 500,498 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 87d
  Chief Financial Officer Martini Gregory S. was granted 136,612 shares, increasing direct ownership by 85% to 297,213 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 87d
  SVP, CMO, Head-Res&Drug Shetzline Michael was granted 136,612 shares, increasing direct ownership by 26% to 658,037 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 87d
  Principal Accounting Officer Silver Ronald was granted 163,934 shares, increasing direct ownership by 65% to 416,570 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 87d
  Chief Commercial Officer Gaskins Tammi L was granted 136,612 shares, increasing direct ownership by 64% to 350,350 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 87d
  Chief Executive Officer Mccourt Thomas A was granted 409,836 shares, increasing direct ownership by 28% to 1,898,838 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 102d
  Chief Legal Officer John Minardo sold $136,177 worth of shares (36,492 units at $3.73), decreasing direct ownership by 9% to 363,886 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 102d
  SVP, CMO, Head-Res&Drug Shetzline Michael sold $59,322 worth of shares (15,570 units at $3.81), decreasing direct ownership by 6% to 521,425 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 102d
  Chief Executive Officer Mccourt Thomas A sold $739,929 worth of shares (198,283 units at $3.73), decreasing direct ownership by 12% to 1,489,002 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 102d
  Chief Commercial Officer Gaskins Tammi L sold $80,328 worth of shares (21,526 units at $3.73), decreasing direct ownership by 9% to 213,738 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 102d
  Chief Financial Officer Martini Gregory S. sold $81,888 worth of shares (21,944 units at $3.73), decreasing direct ownership by 12% to 160,601 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 102d
  Principal Accounting Officer Silver Ronald sold $90,206 worth of shares (24,173 units at $3.73), decreasing direct ownership by 9% to 252,636 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 151d
  Principal Accounting Officer Silver Ronald sold $162,914 worth of shares (35,416 units at $4.60), decreasing direct ownership by 11% to 276,809 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 172d
  Director Denner Alexander J was granted 4,178 shares, increasing direct ownership by 2% to 251,858 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 200d
  Chief Commercial Officer Gaskins Tammi L sold $19,973 worth of shares (6,016 units at $3.32), decreasing direct ownership by 2% to 235,264 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 263d
  Director Denner Alexander J was granted 11,718 shares, increasing direct ownership by 5% to 247,680 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 298d
  Chief Commercial Officer Gaskins Tammi L sold $1,105 worth of shares (1,316 units at $0.84), decreasing direct ownership by 0.54% to 241,280 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 298d
  Chief Legal Officer John Minardo sold $6,513 worth of shares (7,754 units at $0.84), decreasing direct ownership by 2% to 400,378 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 298d
  Chief Financial Officer Martini Gregory S. sold $1,063 worth of shares (1,265 units at $0.84), decreasing direct ownership by 0.69% to 182,545 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 298d
  Principal Accounting Officer Silver Ronald sold $2,391 worth of shares (2,846 units at $0.84), decreasing direct ownership by 1% to 276,809 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 355d
  Director Denner Alexander J was granted 24,193 shares, increasing direct ownership by 11% to 235,962 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Kessler Marla L was granted 45,000 shares, increasing direct ownership by 37% to 165,883 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Shepard Jay was granted 45,000 shares, increasing direct ownership by 36% to 171,555 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Moukheibir Catherine was granted 45,000 shares, increasing direct ownership by 62% to 117,944 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Duane Jon R was granted 45,000 shares, increasing direct ownership by 31% to 190,339 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Currie Mark G was granted 45,000 shares, increasing direct ownership by 8% to 613,419 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Mchugh Julie was granted 45,000 shares, increasing direct ownership by 27% to 208,839 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Dreyfus Andrew was granted 45,000 shares, increasing direct ownership by 25% to 228,313 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 360d
  Director Denner Alexander J was granted 45,000 shares, increasing direct ownership by 27% to 211,769 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 383d
  Chief Executive Officer Mccourt Thomas A sold $7,745 worth of shares (13,353 units at $0.58) and was granted 540,000 shares, increasing direct ownership by 45% to 1,687,281 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 383d
  Chief Commercial Officer Gaskins Tammi L sold $1,487 worth of shares (2,563 units at $0.58), decreasing direct ownership by 1% to 242,596 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 429d
  Director Denner Alexander J was granted 10,416 shares, increasing direct ownership by 7% to 166,769 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 443d
  New insider Gaskins Tammi L claimed ownership of 245,159 shares (SEC Form 3)

  3 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 480d
  Chief Executive Officer Mccourt Thomas A sold $244,753 worth of shares (139,064 units at $1.76), decreasing direct ownership by 11% to 1,160,634 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 480d
  Principal Accounting Officer Silver Ronald sold $21,204 worth of shares (12,048 units at $1.76), decreasing direct ownership by 4% to 279,655 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 480d
  SVP, CMO, Head-Res&Drug Shetzline Michael sold $72,633 worth of shares (41,269 units at $1.76) and was granted 133,333 shares, increasing direct ownership by 20% to 554,007 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 480d
  Chief Legal Officer John Minardo was granted 122,222 shares and sold $68,531 worth of shares (38,938 units at $1.76), increasing direct ownership by 26% to 408,132 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 480d
  Chief Financial Officer Martini Gregory S. sold $21,212 worth of shares (12,052 units at $1.76), decreasing direct ownership by 6% to 183,810 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 494d
  Principal Accounting Officer Silver Ronald was granted 133,333 shares, increasing direct ownership by 84% to 291,703 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 494d
  Chief Financial Officer Martini Gregory S. was granted 111,111 shares, increasing direct ownership by 131% to 195,862 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 494d
  New insider Martini Gregory S. claimed ownership of 84,751 shares (SEC Form 3)

  3 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 501d
  SVP, CMO, Head-Res&Drug Shetzline Michael was granted 48,224 shares, increasing direct ownership by 12% to 461,943 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 501d
  Chief Legal Officer John Minardo was granted 40,187 shares, increasing direct ownership by 14% to 324,848 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 501d
  Chief Executive Officer Mccourt Thomas A was granted 147,354 shares, increasing direct ownership by 13% to 1,299,698 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 536d
  Director Denner Alexander J was granted 4,249 shares, increasing direct ownership by 3% to 156,353 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 564d
  SVP, Chief Business Officer Davis Andrew sold $21,869 worth of shares (5,360 units at $4.08), decreasing direct ownership by 2% to 284,685 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 564d
  SVP, COO and CFO Emany Sravan Kumar sold $44,884 worth of shares (11,001 units at $4.08), decreasing direct ownership by 3% to 309,572 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 627d
  Director Denner Alexander J was granted 3,282 shares, increasing direct ownership by 2% to 152,104 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 662d
  Chief Legal Officer John Minardo sold $42,316 worth of shares (9,910 units at $4.27), decreasing direct ownership by 3% to 284,661 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 662d
  Principal Accounting Officer Silver Ronald sold $13,267 worth of shares (3,107 units at $4.27), decreasing direct ownership by 2% to 158,370 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Shepard Jay was granted 24,311 shares, increasing direct ownership by 24% to 126,555 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Currie Mark G was granted 24,311 shares, increasing direct ownership by 4% to 568,419 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Moukheibir Catherine was granted 24,311 shares, increasing direct ownership by 50% to 72,944 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Dreyfus Andrew was granted 24,311 shares, increasing direct ownership by 15% to 188,230 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Denner Alexander J was granted 24,311 shares, increasing direct ownership by 20% to 148,822 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Kessler Marla L was granted 24,311 shares, increasing direct ownership by 25% to 120,883 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Duane Jon R was granted 24,311 shares, increasing direct ownership by 20% to 145,339 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
• 716d
  Director Mchugh Julie was granted 24,311 shares, increasing direct ownership by 17% to 163,839 units (SEC Form 4)

  4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)